Multimodal Pharmacological Assessment of <i>Arenga porphyrocarpa</i> Palm Leaves and Stems Extracts: Insights From In Vivo, In Vitro, and In Silico Approaches

<i>Arenga porphyrocarpa</i> palm tree roots and buds are used to treat urinary incontinence, fever, appetite loss, and as a diuretic. Our study aimed to evaluate the neuropharmacological, antioxidant, cytotoxic, and thrombolytic potentials of <i>A. porphyrocarpa</i> leaf and stem extracts through in vivo, in vitro and in silico studies. Different fractions of <i>A. porphyrocarpa</i> leaves and stems were investigated for anxiolytic and anti-depressant efficacy through EPM and HBT and TST and FST tests. The anti-oxidant assessment was assessed by using DPPH and reducing power assays, while thrombolytic efficacy was analyzed by clot lysis technique. Computational methods like in silico molecular docking, pass prediction and ADME/T were applied to evaluate several pharmacological properties of 15 selected compounds from GC-MS analysis of plant extract. Both doses of the plant extract fractions (200 and 400 mg/kg) showed dose-dependent anxiolytic and antidepressant-like effects in mice, with the 400 mg/kg dose found to have highly significant (<i>p</i> < 0.001) effects. Among the fractions, the chloroform fraction of <i>A. porphyrocarpa</i> leaves (CFAPL) exhibited the strongest antioxidant activity, as indicated by its DPPH scavenging potential (IC₅₀ = 128.94 μg/mL), and also demonstrated the most effective clot lysis. In silico analysis further revealed that several bioactive compounds had strong binding affinities to target proteins, including isobutyric acid 2,2,2-trichloroethyl ester (anxiolytic activity), 2-cyclobutene-1-carboxamide (antidepressant activity), 2-pyridinecarboxylic acid (antioxidant activity), propionic acid 3-(isobutylthio)- (cytotoxic), and 2-propanone 1-hydroxy- (thrombolytic activity). Ongoing investigations indicate that <i>A. porphyrocarpa</i> is a promising candidate for the treatment of neuropsychiatric and cardiovascular disorders; however, further cytotoxicity studies and confirmation of the specific bioactive compounds responsible for its biological activities are needed.

Authors

Institutions

Publication Details

Journal
Food Science & Nutrition
Published
2025-11-01
DOI
https://doi.org/10.1002/fsn3.71178
Citations
1
Primary Topic
Medicinal Plant Research
Type
article
Field-Weighted Citation Impact
1.75
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multimodal Pharmacological Assessment of Arenga porphyrocarpa Palm Leaves and Stems Extracts: Insights From In Vivo, In Vitro, and In Silico Approaches

Syed Mohammed Tareq, Fahmida Tasnim Richi, Fowzul Islam Fahad, Safaet Alam et al.
1 citations
Food Science & Nutrition
Medicinal Plant Research
1.75
article

Multimodal Pharmacological Assessment of Arenga porphyrocarpa Palm Leaves and Stems Extracts: Insights From In Vivo, In Vitro, and In Silico Approaches

Syed Mohammed Tareq, Fahmida Tasnim Richi, Fowzul Islam Fahad, Safaet Alam, Muhammad Mutasim Billah, Mohammad Nazmul Islam, Koushik Barua, Rasel Khan, Md. Sohel Rana, S.M. Asadul Karim Azad, Jahid Hasan Azad
article en
1 citations

Abstract

<i>Arenga porphyrocarpa</i> palm tree roots and buds are used to treat urinary incontinence, fever, appetite loss, and as a diuretic. Our study aimed to evaluate the neuropharmacological, antioxidant, cytotoxic, and thrombolytic potentials of <i>A. porphyrocarpa</i> leaf and stem extracts through in vivo, in vitro and in silico studies. Different fractions of <i>A. porphyrocarpa</i> leaves and stems were investigated for anxiolytic and anti-depressant efficacy through EPM and HBT and TST and FST tests. The anti-oxidant assessment was assessed by using DPPH and reducing power assays, while thrombolytic efficacy was analyzed by clot lysis technique. Computational methods like in silico molecular docking, pass prediction and ADME/T were applied to evaluate several pharmacological properties of 15 selected compounds from GC-MS analysis of plant extract. Both doses of the plant extract fractions (200 and 400 mg/kg) showed dose-dependent anxiolytic and antidepressant-like effects in mice, with the 400 mg/kg dose found to have highly significant (<i>p</i> < 0.001) effects. Among the fractions, the chloroform fraction of <i>A. porphyrocarpa</i> leaves (CFAPL) exhibited the strongest antioxidant activity, as indicated by its DPPH scavenging potential (IC₅₀ = 128.94 μg/mL), and also demonstrated the most effective clot lysis. In silico analysis further revealed that several bioactive compounds had strong binding affinities to target proteins, including isobutyric acid 2,2,2-trichloroethyl ester (anxiolytic activity), 2-cyclobutene-1-carboxamide (antidepressant activity), 2-pyridinecarboxylic acid (antioxidant activity), propionic acid 3-(isobutylthio)- (cytotoxic), and 2-propanone 1-hydroxy- (thrombolytic activity). Ongoing investigations indicate that <i>A. porphyrocarpa</i> is a promising candidate for the treatment of neuropsychiatric and cardiovascular disorders; however, further cytotoxicity studies and confirmation of the specific bioactive compounds responsible for its biological activities are needed.

Food Science & NutritionVol. 13(11)
International Islamic University Chittagong (BD), Bangladesh Council of Scientific and Industrial Research (BD), University of Dhaka (BD), University of Asia Pacific (BD), Jahangirnagar University (BD)
Openalex Percentile: Top 11%
Medicinal Plant Research
1.75
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.